Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

China Pharma Ups Q3 Revenue Guidance

publication date: Sep 18, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Pharma Holdings forecast that its Q3 revenues would grow between 40% and 45% over the year-previous figures. That would be a better performance than Q2, during which revenues climbed 32%. In the first quarter, however, China Pharma reported a 60% jump in its top line. The single analyst who follows China Pharma is predicting a 33% gain in Q3. An increase to 40% growth would take the company’s revenues $500,000 higher to approximately $11.5 million. More details...

Stock Symbol: (OTCBB: CPHI)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners